Recursion Pharmaceuticals...
(RXRX)
undefined
undefined%
At close: undefined
7.00
0.86%
After-hours Dec 13, 2024, 07:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 391.56M | 549.91M | 285.12M | 262.13M | 69.88M |
Short-Term Investments | - | - | 231.45M | - | - |
Long-Term Investments | - | 7.92M | 8.68M | - | - |
Other Long-Term Assets | 6.89M | 7.92M | 8.72M | 650.00K | 663.00K |
Receivables | 3.09M | 2.75M | 9.09M | 156.00K | 151.00K |
Inventory | - | 1.28M | 1.55M | 5.04M | 5.29M |
Other Current Assets | 43.48M | 17.15M | 9.07M | 2.16M | 1.08M |
Total Current Assets | 438.14M | 569.81M | 534.72M | 269.48M | 76.40M |
Property-Plant & Equipment | 120.17M | 121.45M | 64.72M | 25.97M | 24.37M |
Goodwill & Intangibles | 88.50M | 2.11M | 2.19M | 2.49M | - |
Total Long-Term Assets | 215.56M | 131.47M | 75.63M | 29.11M | 25.03M |
Total Assets | 653.70M | 701.29M | 610.35M | 298.58M | 101.43M |
Account Payables | 3.95M | 4.59M | 2.82M | 1.07M | 1.26M |
Deferred Revenue | 36.43M | 56.73M | 10.00M | 10.00M | - |
Short-Term Debt | 12.27M | 12.00M | 1.51M | 2.01M | 77.00K |
Other Current Liabilities | 40.52M | 26.95M | 32.33M | 19.74M | 5.05M |
Total Current Liabilities | 93.17M | 100.27M | 46.66M | 23.10M | 6.68M |
Long-Term Debt | 44.52M | 44.96M | 9.97M | 14.12M | 15.63M |
Other Long-Term Liabilities | - | - | 4.11M | 450.99M | 203.39M |
Total Long-Term Liabilities | 97.09M | 115.22M | 20.75M | 481.77M | 219.01M |
Total Liabilities | 190.26M | 215.48M | 67.41M | 504.87M | 225.70M |
Total Debt | 50.67M | 51.01M | 11.48M | 15.66M | 16.17M |
Common Stock | 2.00K | 2.00K | 2.00K | - | - |
Retained Earnings | -967.62M | -639.56M | -400.08M | -213.60M | -126.59M |
Comprehensive Income | -0.00 | 0.00 | -126.00K | - | - |
Shareholders Equity | 463.44M | 485.81M | 542.94M | -206.29M | -124.27M |
Total Investments | 6.63M | 7.92M | 231.45M | - | - |